Axcella Health Inc. (AXLA) PT Lowered to $8 at Goldman Sachs
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
Tweet
Share
E-mailGet Alerts AXLA Hot Sheet
Price: $4.58 --0%
Rating Summary:
7 Buy, 3 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 9 | New: 7
Rating Summary:
7 Buy, 3 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 9 | New: 7
Join SI Premium – FREE
Goldman Sachs analyst Paul Choi lowered the price target on Axcella Health Inc. (NASDAQ: AXLA) to $8.00 (from $10.00) while maintaining a Buy rating.
You May Also Be Interested In
- Constellation Brands (STZ) PT Raised to $142 at Jefferies
- Abbvie (ABBV) PT Raised to $340 at Wells Fargo
- Permian Resources Corp (PR) PT Raised to $34 at Raymond James
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
